Cardiovascular disease and cancer are the two leading causes of mortality worldwide. (1) Advances in oncologic therapies have improved cancer survival, resulting in a growing population of patients with active malignancy or cancer survivors who remain at increased risk of cardiovascular and non-cancer mortality....
A. Afana, S. Duhamel, S. Toupin et al.· European Heart Journal· 0 citations
BACKGROUND
Although the prognostic value of vasodilator stress cardiovascular magnetic resonance (CMR) is established, it has never been assessed in patients <45 years with suspected coronary artery disease. The aim was to assess the long-term prognostic value of stress CMR to predict mortality in a multicenter cohort...
Elsa Richard de Vesvrotte, J. Garot, S. Duhamel et al.· Journal of Cardiovascular Ma...· 0 citations
In patients with early-stage TNBC treated with pembrolizumab, cardiotoxicity was frequent and associated with a significant reduction in overall survival, and larger prospective studies are required to better characterise predictors of cardiotoxicity in this setting.
L. Dib, B. Sibila, C. Regragui et al.· European Heart Journal, Supp...· 0 citations
